Carlsbad, CA's SynteractHCR is deploying some new manpower in the fight against lung diseases. In addition to its clinical efforts to find better drugs for respiratory conditions, the company will send a team to raise money at the American Lung Association's "Fight for Air Climb."
The CRO team will climb the flights of stairs of a skyscraper on Sunday, April 10, to raise funds that'll support the American Lung Association's efforts. SynteractHCR conducts clinical research for drugs addressing related diseases such as asthma, cystic fibrosis, tuberculosis and lung cancer, its release said.
The fundraiser will have participants climb to the 32nd floor at One America Plaza in San Diego--657 steps--or do the course twice for a total of 1314 steps. Event organizers have developed an app to help participants raise money and grow involvement.
As of Tuesday, the event has raised 60% of its $100,000 goal. So far, the Celgene ($CELG) team has raised the most toward the goal with that team's participation at about $3,300.
Formed in 2013 with Synteract's buyout of Harrison Clinical Research, SynteractHCR has conducted Phase I to Phase IV studies in 60 countries in fields including oncology, immunotherapy, CNS, infectious disease, endocrinology, cardiovascular and respiratory.